Literature DB >> 3908400

Migraine and cluster headache treatment with calcium antagonists supports a vascular pathogenesis.

J S Meyer, M Nance, M Walker, W J Zetusky, R E Dowell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908400     DOI: 10.1111/j.1526-4610.1985.hed2507358.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  10 in total

1.  Episodic paroxysmal hemicrania responsive to calcium channel blockers.

Authors:  F Coria; L E Claveria; F J Jimenez-Jimenez; E V de Seijas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

2.  [Not Available].

Authors:  K H Grotemeyer
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

3.  Calcium entry blocker: treatment in acute pain in cluster headache patients.

Authors:  A Boiardi; M Gemma; E Porta; C Peccarisi; G Bussone
Journal:  Ital J Neurol Sci       Date:  1986-10

4.  Development of tolerance to nifedipine in patients with stable angina pectoris.

Authors:  S Y Martsevich; V I Metelitsa; D O Rumiantsev; V K Piotrovskii; I D Slastnikova; L V Egorov; V A Vygodin
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 5.  Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors:  K J Tietze; M L Schwartz; P H Vlasses
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

6.  Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.

Authors:  I Jansen; P Tfelt-Hansen; L Edvinsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Nimodipine in migraine: clinical efficacy and endocrinological effects.

Authors:  R Formisano; P Falaschi; R Cerbo; A Proietti; T Catarci; R D'Urso; C Roberti; V Aloise; F Chiarotti; A Agnoli
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.

Authors:  G Nappi; G Sandrini; G Savoini; A Cavallini; C de Rysky; G Micieli
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?

Authors:  Joachim Alexandre; Xavier Humbert; Marion Sassier; Paul Milliez; Antoine Coquerel; Sophie Fedrizzi
Journal:  Drug Saf Case Rep       Date:  2015-12

10.  Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss.

Authors:  Mehdi Abouzari; Khodayar Goshtasbi; Janice T Chua; Donald Tan; Brooke Sarna; Tina Saber; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope       Date:  2020-04-03       Impact factor: 3.325

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.